While Erk1/2-NF-κB pathway was reported to be partially involved in inflammatory factors TGF-β1, TNF-α and IL-6 correlated lung cancer invasion [53], p38-NF-κB and STAT3-NF-κB pathways were demonstrated to inhibit miR-365 expression and regulate IL-6 repressing miR-98 levels respectively [54–55]. Here, MAPK3 is linked to lung carcinoma.